Skip to main content
. 2024 Aug 16;14(8):e086394. doi: 10.1136/bmjopen-2024-086394

Table 3. Operating characteristics of the continuous reassessment model.

Starting dose level 1, dose-skipping not allowed, 3 dose levels, maximum 24 participants.Skeleton (a priori probabilities of DLE) = 0.05, 0.11, 0.20target DLE rate=no greater than 20%
Dose level
1 2 3
Scenario 1: recommendation (%) 2.5 24.5 73.0
Scenario 2: recommendation (%) 22.5 46.5 31.0
Scenario 3: recommendation (%) 0.0 3.3 96.7
Scenario 1: true probabilities=a priori probabilitiesScenario 2: true probabilities=0.10, 0.20, 0.30Scenario 3: true probabilities=0.02, 0.05, 0.10

DLEdose-limiting event